Back to News
Market Impact: 0.22
MegazoneCloud Begins Building Hanmi Pharmaceutical's Quality Assurance AI Agent with 'AIR Studio'
Source: PR Newswire
Artificial IntelligenceTechnology & InnovationHealthcare & Biotech
A South Korean consortium involving Hanmi Pharmaceutical, Samsung SDS, and Selectstar is deploying a fine-tuned Korean Solar AI model on AIR Studio to automate pharmaceutical quality-document operations. The initiative is part of South Korea's MSIT-NIPA AX One-Stop Voucher Program, signaling targeted enterprise AI adoption in regulated life-sciences workflows.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.32
More News
- Microsoft offers buyouts to nearly 30% of workforce in ongoing AI shift
- From Wall Street to Silicon Valley, Anthropic IPO poised to have massive 'trickle-down effect'
- Anthropic’s IPO filing shows explosive growth, risks and staggering costs
- EQT becomes the nation’s leading natural gas ‘juggernaut’ with a $13B deal as data center, export demand surges
- Meta announces $95 billion stock offering to fund AI expansion
- Elon Musk warns more than 200 AI cloud companies face ‘guppy-level death’ as the AI boom runs into a debt crisis